Dopamine receptor type 2 (<scp>DRD2</scp>) and somatostatin receptor type 2 (<scp>SSTR2</scp>) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumorsErika Peverelli, Giovanna Mantovani|International Journal of Cancer|2017Cited by 60
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph CellsDonatella Treppiedi, Erika Peverelli|Neuroendocrinology|2019Cited by 19
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cellsRosa Catalano, Erika Peverelli|Cancer Letters|2020Cited by 17
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 InfectionDonatella Treppiedi, Erika Peverelli|Frontiers in Endocrinology|2022Cited by 8
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomasEmanuela Esposito, Erika Peverelli|International Journal of Cancer|2024Cited by 6